alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid has been researched along with Conjugate Nystagmus in 3 studies
alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Toyota, H | 1 |
| Shimogori, H | 3 |
| Sugahara, K | 1 |
| Yamashita, H | 3 |
| Takemoto, T | 1 |
| Mikuriya, T | 1 |
3 other studies available for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid and Conjugate Nystagmus
| Article | Year |
|---|---|
A novel treatment for vestibular disorder with FGLM-NH2 plus SSSR.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Drug Therapy, Combination; Ear, I | 2012 |
Peripheral vestibular disorder induced by (+/-)-alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid (AMPA).
Topics: 6-Cyano-7-nitroquinoxaline-2,3-dione; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Anim | 2004 |
Edaravone protects the vestibular periphery from free radical-induced toxicity in response to perilymphatic application of (+/-)-alpha-amino-3-hydroxy-5-methyl-isoxazole-4-propionic acid.
Topics: Aldehydes; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Antipyrine; Edaravone; | 2007 |